Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy (Q39546286)

12 September 2017

1 reference

title

Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy (English)

1 reference

12 September 2017

D S Ross

1

1 reference

PubMed ID

3059080

12 September 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

12 September 2017

1 reference

12 September 2017

63

1 reference

12 September 2017

12

1 reference

12 September 2017

1223-1229

1 reference

Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

L-thyroxine dosage: a reevaluation of therapy with contemporary preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Reevaluation of L-thyroxine dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Oral thyroxine: variation in biologic action and tablet content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Bone loss in hypothyroidism with hormone replacement. A histomorphometric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

The Role of Thyroid Hormone Deiodination in the Regulation of Hypothalamo-Pituitary Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Triiodothyronine rapidly decreases transcription of the thyrotropin subunit genes in thyrotropic tumor explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Spectrum of Pituitary Alteration with Mild and Severe Thyroid Impairment* †

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Compromise therapy in the patient with angina pectoris and hypothyroidism. A clinical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965409-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)65409-3

1 reference

12 September 2017

1 reference

PubMed ID

3059080